1. 17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1
- Author
-
Florence Petit, Joëlle Cohen-Tannoudji, Isabelle Ray-Coquard, Charlotte M. François, Thibaut Goulvent, Ruth Rimokh, Isabelle Treilleux, Valeria Zazzu, Richard Wargnier, and Céline J. Guigon
- Subjects
Adult ,endocrine system ,Cancer Research ,Pathology ,medicine.medical_specialty ,Granulosa cell ,Blotting, Western ,Cell ,Fluorescent Antibody Technique ,Estrogen receptor ,Original Manuscript ,Apoptosis ,Biology ,Gene Expression Regulation, Enzymologic ,Receptors, G-Protein-Coupled ,Metastasis ,Immunoenzyme Techniques ,Young Adult ,Cell Movement ,Cell Adhesion ,Tumor Cells, Cultured ,medicine ,Humans ,Neoplasm Metastasis ,RNA, Small Interfering ,Aged ,Cell Proliferation ,Granulosa Cell Tumor ,Tissue microarray ,Estradiol ,Cell growth ,Cancer ,Estrogens ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,medicine.anatomical_structure ,Receptors, Estrogen ,Tissue Array Analysis ,Female ,Neoplasm Recurrence, Local ,Signal transduction ,hormones, hormone substitutes, and hormone antagonists ,Signal Transduction - Abstract
Granulosa cell tumor (GCT) is a rare and severe form of sex-cord stromal ovarian tumor that is characterized by its long natural history and tendency to recur years after surgical ablation. Because there is no efficient curative treatment beyond surgery, ~20% of patients die of the consequences of their tumor. However, very little is known of the molecular etiology of this pathology. About 70% of GCT patients present with elevated circulating estradiol (E2). Because this hormone is known to increase tumor growth and progression in a number of cancers, we investigated the possible role of E2 in GCTs. Cell-based studies with human GCT metastases and primary tumor-derived cells, ie KGN and COV434 cells, respectively, aimed at evaluating E2 effect on cell growth, migration and invasion. Importantly, we found that E2 did not affect GCT cell growth, but that it significantly decreased the migration and matrix invasion of metastatic GCT cells. Noteworthy, our molecular studies revealed that this effect was accompanied by the inhibition through non-genomic mechanisms of extracellular signal-regulated kinase 1/2 (ERK1/2), which is constitutively activated in GCTs. By using pharmacological and RNA silencing approaches, we found that E2 action was mediated by G protein-coupled estrogen receptor 1 (GPER1) signaling pathway. Analyses of GPER1 expression on tissue microarrays from human GCTs confirmed its expression in ~90% of GCTs. Overall, our study reveals that E2 would act via non-classical pathways to prevent metastasis spreading in GCTs and also reveals GPER1 as a possible target in this disease.
- Published
- 2015
- Full Text
- View/download PDF